Citigroup Maintains Buy on Cardinal Health, Raises Price Target to $265
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $245 to $265.